Tina Deignan
About Tina Deignan
Tina Deignan is the Senior Vice President and US Business Unit Head for Immunology at Bristol Myers Squibb and a board member at Trinity Health Mid-Atlantic, with over 20 years of experience in the pharmaceutical industry.
Title
Tina Deignan holds the title of Senior Vice President and US Business Unit Head for Immunology at Bristol Myers Squibb.
Current Positions
Tina Deignan currently serves as a Senior Vice President and US Business Unit Head for Immunology at Bristol Myers Squibb in East Hanover, NJ. Additionally, she is a board member at Trinity Health Mid-Atlantic.
Past Work Experience
Tina Deignan's previous positions included Director of Marketing and Myfortic Brand Lead at Novartis from 2000 to 2007, and a Post Doctoral Research Scientist at University College Dublin from 1997 to 2000.
Education and Expertise
Tina Deignan has a robust educational background in biochemistry, immunology, and marketing. She earned a BSc in Biochemistry from the National University of Ireland, Galway (1988-1992), followed by a PhD in Immunology from Trinity College Dublin (1992-1997). She also achieved a GDBS in Marketing from Dublin Business School (1999-2000).
Achievements and Industry Contributions
Tina Deignan has over 20 years of experience in the pharmaceutical industry, with a focus on immunology and marketing. She has played a key role in launching multiple immunology products at Bristol Myers Squibb and is actively involved in mentoring young professionals. Deignan supports policies promoting health equity, bioequivalent drug development, and tiered pricing for HIV medicines. She is committed to patient safety, public health, and innovative research for immune-mediated diseases.